Atypical response with bone pseudoprogression in a patient receiving nivolumab for advanced cutaneous squamous cell carcinoma

Currently, there is no established standard of care for patients with metastatic CSCC. Based on the mechanisms of CSCC carcinogenesis has been postulated that these tumors may be amenable to PD-1/PD-L1 blockade. This case illustrates a patient with CSCC with nodal involvement and pulmonary metastase...

Descripción completa

Detalles Bibliográficos
Autores principales: Oliveira, Leandro J. C., Gongora, Aline B. L., Barbosa, Felipe G., dos Anjos, Carlos H., Munhoz, Rodrigo R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6258146/
https://www.ncbi.nlm.nih.gov/pubmed/30482243
http://dx.doi.org/10.1186/s40425-018-0444-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6258146/
https://www.ncbi.nlm.nih.gov/pubmed/30482243
http://dx.doi.org/10.1186/s40425-018-0444-5

Ejemplares similares